BPC-157's Stomach Protection Lasts Long After the Drug Is Gone
BPC-157's cytoprotective effect in the gut persists for days after administration, outperforming ranitidine and sucralfate in duration of protection against reflux esophagitis.
Quick Facts
What This Study Found
BPC-157 provided long-lasting cytoprotection lasting days after administration in gastrectomized rats with duodenal ulcers and reflux esophagitis, significantly outlasting ranitidine and sucralfate.
Key Numbers
How They Did This
Animal study in gastrectomized rats challenged with cysteamine. BPC-157, ranitidine, sucralfate, and cholestyramine were administered, and protection was assessed at multiple timepoints to evaluate duration.
Why This Research Matters
A drug whose protection outlasts its presence in the body suggests it activates lasting cellular repair programs. This is fundamentally different from acid blockers that only work while present.
The Bigger Picture
The concept of long-lasting cytoprotection suggests BPC-157 reprograms cellular defense mechanisms. If it can induce sustained protection, dosing frequency could be much lower than conventional drugs.
What This Study Doesn't Tell Us
Animal model in gastrectomized rats, which is specialized. The specific cellular programs activated for lasting protection were not identified.
Questions This Raises
- ?What cellular mechanisms does BPC-157 activate for lasting protection?
- ?How does this lasting effect inform optimal human dosing schedules?
- ?Does the long-lasting protection apply to other tissue types beyond gut?
Trust & Context
- Key Stat:
- Days-long protection BPC-157's cytoprotective effect persisted for days after administration, far exceeding the duration of ranitidine or sucralfate protection
- Evidence Grade:
- Preliminary animal evidence with innovative experimental design testing duration of protection, providing unique mechanistic insight.
- Study Age:
- Published in 1999. The concept of BPC-157's lasting cytoprotection has influenced subsequent dosing research.
- Original Title:
- Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.
- Published In:
- Journal of physiology, Paris, 93(6), 467-77 (1999)
- Authors:
- Sikiric, P(36), Jadrijevic, S(2), Seiwerth, S(42), Sosa, T, Deskovic, S, Perovic, D, Aralica, G, Grabarevic, Z, Rucman, R, Petek, M, Jagic, V, Turkovic, B, Ziger, T, Rotkvic, I, Mise, S, Zoricic, I, Sebecic, B, Patrlj, L, Kocman, B, Sarlija, M, Mikus, D, Separovic, J, Hanzevacki, M, Gjurasin, M, Miklic, P
- Database ID:
- RPEP-00559
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How long does BPC-157's protection last?
In this study, a single dose protected the gut for days afterward — much longer than the peptide itself would be present in the body. This suggests it triggers lasting repair mechanisms rather than just temporarily coating the stomach.
Does this mean you don't need to take it every day?
This animal study suggests BPC-157's effects persist well beyond its presence. If confirmed in humans, it could potentially be taken less frequently than conventional gut medications.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00559APA
Sikiric, P; Jadrijevic, S; Seiwerth, S; Sosa, T; Deskovic, S; Perovic, D; Aralica, G; Grabarevic, Z; Rucman, R; Petek, M; Jagic, V; Turkovic, B; Ziger, T; Rotkvic, I; Mise, S; Zoricic, I; Sebecic, B; Patrlj, L; Kocman, B; Sarlija, M; Mikus, D; Separovic, J; Hanzevacki, M; Gjurasin, M; Miklic, P. (1999). Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.. Journal of physiology, Paris, 93(6), 467-77.
MLA
Sikiric, P, et al. "Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.." Journal of physiology, 1999.
RethinkPeptides
RethinkPeptides Research Database. "Long-lasting cytoprotection after pentadecapeptide BPC 157, ..." RPEP-00559. Retrieved from https://rethinkpeptides.com/research/sikiric-1999-longlasting-cytoprotection-after-pentadecapeptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.